ZA876806B - Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist - Google Patents
Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonistInfo
- Publication number
- ZA876806B ZA876806B ZA876806A ZA876806A ZA876806B ZA 876806 B ZA876806 B ZA 876806B ZA 876806 A ZA876806 A ZA 876806A ZA 876806 A ZA876806 A ZA 876806A ZA 876806 B ZA876806 B ZA 876806B
- Authority
- ZA
- South Africa
- Prior art keywords
- thromboxane
- antagonist
- pharmaceutical composition
- phosphodiesterase inhibitor
- phosphodiesterase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863631294 DE3631294A1 (de) | 1986-09-13 | 1986-09-13 | Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA876806B true ZA876806B (en) | 1989-05-30 |
Family
ID=6309586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA876806A ZA876806B (en) | 1986-09-13 | 1987-09-11 | Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0260527B1 (xx) |
JP (1) | JPS6379838A (xx) |
KR (1) | KR880003624A (xx) |
AU (1) | AU597718B2 (xx) |
DE (2) | DE3631294A1 (xx) |
DK (1) | DK472487A (xx) |
ES (1) | ES2033755T3 (xx) |
GR (1) | GR3004969T3 (xx) |
IL (1) | IL83872A0 (xx) |
NZ (1) | NZ221779A (xx) |
PH (1) | PH23553A (xx) |
ZA (1) | ZA876806B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306846A3 (de) * | 1987-09-11 | 1990-05-02 | Dr. Karl Thomae GmbH | Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
EP1216037A2 (en) | 1999-09-21 | 2002-06-26 | Emory University | Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291368A (en) * | 1979-03-30 | 1981-09-22 | Borg-Warner Corporation | Pulse-width modulated inverter system and method |
DE3166627D1 (en) * | 1980-12-12 | 1984-11-15 | Thomae Gmbh Dr K | Pyrimidones, their preparation and medicines containing them |
DE3049207A1 (de) * | 1980-12-27 | 1982-07-29 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel |
US4568676A (en) * | 1983-11-25 | 1986-02-04 | Thomas Jefferson University | Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor |
-
1986
- 1986-09-13 DE DE19863631294 patent/DE3631294A1/de not_active Withdrawn
-
1987
- 1987-09-01 PH PH35759A patent/PH23553A/en unknown
- 1987-09-02 EP EP87112773A patent/EP0260527B1/de not_active Expired - Lifetime
- 1987-09-02 DE DE8787112773T patent/DE3777926D1/de not_active Expired - Fee Related
- 1987-09-02 ES ES198787112773T patent/ES2033755T3/es not_active Expired - Lifetime
- 1987-09-10 DK DK472487A patent/DK472487A/da not_active Application Discontinuation
- 1987-09-11 IL IL83872A patent/IL83872A0/xx unknown
- 1987-09-11 NZ NZ221779A patent/NZ221779A/xx unknown
- 1987-09-11 AU AU78296/87A patent/AU597718B2/en not_active Ceased
- 1987-09-11 JP JP62228239A patent/JPS6379838A/ja active Pending
- 1987-09-11 ZA ZA876806A patent/ZA876806B/xx unknown
- 1987-09-12 KR KR870010125A patent/KR880003624A/ko not_active Application Discontinuation
-
1992
- 1992-06-18 GR GR920401303T patent/GR3004969T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0260527A3 (en) | 1989-08-09 |
ES2033755T3 (es) | 1993-04-01 |
DE3777926D1 (de) | 1992-05-07 |
KR880003624A (ko) | 1988-05-28 |
GR3004969T3 (xx) | 1993-04-28 |
IL83872A0 (en) | 1988-02-29 |
EP0260527B1 (de) | 1992-04-01 |
PH23553A (en) | 1989-08-25 |
DE3631294A1 (de) | 1988-03-24 |
AU597718B2 (en) | 1990-06-07 |
EP0260527A2 (de) | 1988-03-23 |
NZ221779A (en) | 1990-03-27 |
JPS6379838A (ja) | 1988-04-09 |
DK472487A (da) | 1988-03-14 |
DK472487D0 (da) | 1987-09-10 |
AU7829687A (en) | 1988-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0513846A3 (en) | Scaffolding | |
EP0297625A3 (en) | Pressure-sensitive tablet | |
NZ226002A (en) | Peptidylheterocyclic compounds and pharmaceutical compositions | |
ZA895838B (en) | Pharmaceutical compounds | |
HU893412D0 (en) | Inhibitors of interleucin-1 | |
IL87721A0 (en) | Synergistic pharmaceutical combinations comprising a pde inhibitor and a thromboxane a2 antagonist | |
IL96594A0 (en) | Pharmaceutical compositions containing an antiallergic compound and an antihistamine | |
GR900100679A (en) | Novel pharmaceutical use | |
ZA89260B (en) | Pharmaceutical compounds | |
IL102372A0 (en) | Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist | |
IL88734A0 (en) | Pharmaceutical compositions comprising a comt inhibitor | |
PT80775A (en) | Pharmaceutical agents | |
GB8801936D0 (en) | Explosives devices & methods of use thereof | |
ZA876806B (en) | Pharmaceutical composition comprising a phosphodiesterase inhibitor and a thromboxane a2 antagonist | |
GB8525673D0 (en) | Pharmaceutical agent | |
GB8509165D0 (en) | Pharmaceutical agent | |
GB8810860D0 (en) | Bricklayers spiritlevel | |
EP0427939A3 (en) | Renin inhibitors | |
GB9517463D0 (en) | Improved use of B� bronchodilator drugs | |
GB8810225D0 (en) | Thromboxane antagonists | |
IE872432L (en) | Composition of a phosphodiesterase and a thromboxane a2¹antagonist | |
IE891769L (en) | A pharmaceutical containing tnf inhibitor | |
GB8823568D0 (en) | Novel pharmaceutical use | |
GB8900228D0 (en) | Pharmaceutical use | |
GB8904257D0 (en) | New pharmaceutical use |